FDA grants approval status for Voriconazole supplement by Hainan Poly Pharm
The FDA has granted an approval status (AP) for the supplemental application ANDA220043 for Voriconazole submitted by Hainan Poly Pharm.
Therapeutic Area
Therapeutic area intelligence for Antifungal with 13 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.